Coriolis Pharma, a globally operating service provider for drug product development, analytics and manufacturing support, has introduced Analytical Ultracentrifugation (AUC) under GMP as a service offering. With the introduction of this method under GMP, Coriolis meets the increasing demand in the pharmaceutical and biotech industry and expands its existing portfolio of GMP methods for the […]
Produced using a patented dry-spinning technology – CollaFibR from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering an accurate representation of in-vivo conditions.
Beckman Coulter Diagnostics, a leader in clinical diagnostics, has extended the menu of DxI 9000 Immunoassay Analyzer assays. Recently, tests for Hepatitis B and C viruses – namely Access anti-HCV, Access HBsAg, and Access HBsAg Confirmatory assays – received CE marks.
Waters Corporation has launched the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories.
The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, is partnering with SRG, leaders in life science recruitment, to support the advancement of science professionals in their careers.
Teva UK and Closed Loop Medicine will collaborate to advance the development of personalised medicine. Under the agreement, Closed Loop Medicine – a leading TechBio company – and Teva UK – a pharmaceutical company, will investigate opportunities to use Closed Loop Medicine’s proprietary software as a medical device (SaMD) technology platform which aims to advance […]
Novo Nordisk will acquire Cardior Pharmaceuticals for up to €1.025 billion, including an upfront payment and additional payments if certain development and commercial milestones are achieved.
Beckman Coulter Life Sciences has launched a new high-throughput assay that promises to drastically cut the time required to detect and quantify protein aggregation during monoclonal antibody development.
Shimadzu Corporation has launched the new LCMS-TQ RX Series of triple quadrupole liquid chromatography-mass spectrometry (LC-MS/MS) systems, designed to provide clinical laboratories with greater analytical sensitivity, measurement stability, and operational efficiency.
Preci, a biotechnology company advancing patient-derived cell models to bridge the gap between preclinical testing and clinical trials, and Biopredic International, a biotechnology company specializing in the design and manufacture of human and animal in vitro assay systems, will collaborate on for the production of pooled suspension human hepatocytes.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
